Qualification Desc
He completed his Post Graduate diploma in the speciality of Nuclear Medicine, Diploma in Radiation Medicine (D.R.M.) from premier and pioneer teaching institute in india – Radiation Medicine Centre (BARC) in 2005 followed by Post Graduate Degree - Diplomate of National Board, New Delhi, in 2008 from same place.
He qualified the Radiation Safety Officer Examination in 2005, conducted by Atomic Energy Regulatory Board (AERB), Bhaba Atomic research Centre (BARC), Mumbai, India.
He completed his M.B.B.S in 2001. He has received Gold Medal in Medicine and Ophthalmology and Gold Medal in Forensic Medicine and Toxicology (F.M.T). He was university Rank Holder in final M.B.B.S examination.
• PET-CT in Neurology and Nuclear Neurology, Epilepsy
• PET-CT in Aortoarteritis / Takayasu arteritis, Infections
• Nuclear Cardiology and FDG PET for Myocardial Viability
• Radioactive iodine therapy (I-131 therapy) for hyperthyroidism
• Radioactive iodine therapy (I-131, 131I-MIBG therapy) for thyroid cancer
• Bone pain palliation therapy
• Sentinel node imaging in breast cancer and radioguided surgery
• Parathyroid imaging
• Lu-177 peptide therapy (PRRT) for neuroendocrine tumors
• Nuclear Nephrology
• Pediatric nuclear imaging
Dr. Amit Abhyankar is a Consultant in Nuclear Medicine and PET-CT at P D Hinduja National Hospital & Medical Research Centre, Mumbai, with over 8 years of experience, and is a qualified Post Graduate Medical Teacher.
He has worked in private nuclear medicine centre - SPECT Lab in Pune as Consultant, nuclear medicine physician from Dec 2013 to Nov 2015.
He was worked as assistant professor (scientific officer – D) in radiation medicine Centre (BARC) for four years from Aug 2009 to Nov 2013.
He had participated and represented nation in Regional Training Course on Multi-Modality Approaches in the Diagnosis of Cardiovascular Diseases; organized by IAEA in Gunma Japan in April 2013.
He has vast experience in handling the largest Isolation Ward Facility for High Dose Radio-active Iodine (131I, 177Lu) Therapy and other radio-nuclide for the patients of Thyroid Carcinoma, metastatic bone pain palliation & various Neuro-Endocrine malignancies using PRRT.
He has sound knowledge in every aspect of high dose radioactive treatment planning from pre-treatment assessment, making treatment management decisions, post treatment evaluation and managing the patients in Isolation ward. He has gained uncommon ability in treating the difficult systemic metastases of thyroid and neuroendocrine malignancies in patients with High dose radio-nuclide therapy in isolation ward using 131I, 131I-MIBG and 177Lu.
He has in-depth knowledge of radiation precaution and radiation safety related to various diagnostic and therapeutic procedures.
He specializes in Molecular imaging with extensive work since 2003 in various aspect of nuclear medicine dealing with cancers including lymphoma, breast cancer, lung cancer, bone and soft tissue cancers, cancers of head and neck, cancers of gastrointestinal tract and amongst others. He also specializes in imaging of benign conditions specifically Aortoarteritis / Takayasu disease, infections, fever of unknown origin. He has gained ample of experience using newer PET tracers like 68Ga-PSMA, 68Ga-Peptide for SSTR imaging. His expertise includes Nuclear Cardiology including FDG PET imaging for myocardial viability, Nuclear Neurology with special attention towards Epilepsy, Nuclear Nephrology, Pediatric Nuclear Imaging and various other general Nuclear Medicine Procedures.
He was actively involved in Training Program of postgraduate diploma courses conducted at Radiation Medicine Centre for medical students (D.R.M.) and technologist course for basic science students (D.M.R.I.T.). This involves delivering lectures, conducting seminars, joint clinics and appropriately guiding and teaching the students in the OPD and therapy ward. He had co-Guided one DRM trainee every year for their thesis/ dessertaion for the diploma course from 2009 to 2013.
He is a qualified post graduate Medical Teacher as per the Eligibility Qualifications criteria of Teachers, in accordance with the National Board of Examinations India for medical graduates undergoing training for post graduate specialization (DNB) in Nuclear Medicine. He is part of the faculty conducting Post Graduate training programme for Medical Graduates in the speciality of Nuclear Medicine recognized by the National Board.
- Reverse discordance between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs Nuclear medicine communications 32 (7), 654-658
- FDG uptake in unilateral breast related to breastfeeding practice in a patient of pulmonary hydatid cyst Clinical nuclear medicine 37 (7), 676-678
- Adding surgery as a complementary approach to radioiodine therapy in patients of differentiated thyroid carcinoma with large solitary flat bone metastases: the unresolved issues Journal of surgical oncology 105 (6), 622-622
- F-18 FDG PET findings in a port site recurrence after laparoscopic radical nephrectomy in a patient with renal cell carcinoma Clinical nuclear medicine 33 (2), 146-147
- Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol European journal of nuclear medicine and molecular imaging 41 (9), 1767-1780
- Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables Nuclear medicine communications 35 (2), 205-209
- Bronchoalveolar carcinoma of lung masquerading as iodine avid metastasis in a patient with minimally invasive follicular carcinoma of thyroid Clinical nuclear medicine 33 (1), 26-29
- Role of SPECT/CT, Versus Traditional Practices, in Individualizing Treatment of Thyroid Carcinoma Journal of Nuclear Medicine 53 (11), 1819-1819
- Advantages of surgical extirpation in addition to radioiodine therapy in differentiated thyroid carcinoma patients with a solitary large-volume skeletal metastasis with small-volume oligometastatic disease in the rest of the whole body Journal of cancer research and therapeutics 8 (4), 656
- Detection by (18) F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheek. Hellenic journal of nuclear medicine 14 (3), 307-308
- The current place and indications of 131I-metaiodobenzylguanidine therapy in the era of peptide receptor radionuclide therapy: determinants to consider for evolving the best practice and envisioning a personalized approach Nuclear medicine communications 36 (1), 1-7
- The Use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the Evaluation of Duodenal Neuroendocrine Tumor with Atypical and Extensive Metastasis Responding Dramatically to a Single Fraction of PRRT with 177Lu-DOTATATE Journal of nuclear medicine technology 42 (4), 296-298
- Comparative Evaluation of 24-Hour Thyroid 131I Uptake Between ? Camera–Based Method Using Medium-Energy Collimator and Standard Uptake Probe–Based Method Journal of nuclear medicine technology 42 (3), 194-197
- The Added Clinical Value of 18F-FDG PET/CT in Evaluating Intratracheal Recurrence of Differentiated Thyroid Carcinoma: Implications for Planning Surgery, Assessing Its Completeness, and Planning Radioiodine Therapy Journal of nuclear medicine technology 41 (4), 302-305
- A Logical levothyroxine dose Individualization: Optimization Approach at discharge from Radioiodine therapy ward and during follow-up in patients of Differentiated Thyroid Carcinoma: Balancing the Risk based strategy and the practical issues and challenges: Experience and Views of a large volume referral centre in India Indian journal of nuclear medicine
- Advantages of surgical extirpation in addition to radioiodine therapy in differentiated thyroid carcinoma patients with a solitary large-volume skeletal metastasis with small-volume oligometastatic disease in the rest of the whole body Journal of Cancer Research and Therapeutics 8 (4), 656-657
- 18F-FDG uptake in small bowel intussusception in a patient of Langerhans cell histiocytosis and its resolution following successful conservative medical management. Hellenic journal of nuclear medicine 13 (3), 289
- Potential role of (18 F) FDG PET imaging in defining tumor biology and monitoring therapeutic response in osteosarcoma-a retrospective study
- Thymus uptake of 131 I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice Journal of cancer research and therapeutics 11 (3), 648
- The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study Nuclear medicine communications 37 (1), 74-78
- Estimation of late (24 hour) radioiodine uptake using early (2 hour) uptake measurement in patients of thyrotoxicosis
- Unusual solitary splenic metastasis from pyriform fossa carcinoma detected by FDG-PET. Indian J Cancer. 2015 Oct-Dec;52(4):524-5
Pioneer in the developing and starting nuclear cardiology services in the Nuclear Medicine Department at Shri Siddhivinayak Ganapati Cancer Hospital, Miraj where he designed and developed the stress test Lab for nuclear cardiology studies (myocardial Perfusion imaging)
